...
首页> 外文期刊>British Journal of Haematology >Diagnosis and management of acquired coagulation inhibitors: A guideline from UKHCDO
【24h】

Diagnosis and management of acquired coagulation inhibitors: A guideline from UKHCDO

机译:获得性凝血抑制剂的诊断和管理:UKHCDO的指南

获取原文
获取原文并翻译 | 示例
           

摘要

Acquired coagulation inhibitors result from immune-mediated depletion or inhibition of a coagulation factor. Inhibitors are most commonly directed against factor VIII (FVIII) and von Willebrand factor (VWF) and inhibitors against other coagulation factors are only occasionally reported. Since the publication of previous guidelines (Laffan et al, 2004; Pasi et al, 2004; Hay et al, 2006) substantial new data has been published on acquired FVIII inhibitors, necessitating updated guidelines.
机译:获得性凝血抑制剂是由于免疫介导的耗竭或凝血因子的抑制而产生的。抑制剂最常见的是针对凝血因子VIII(FVIII)和von Willebrand因子(VWF)的药物,仅偶尔报道了针对其他凝血因子的抑制剂。自从先前的指南发布(Laffan等,2004; Pasi等,2004; Hay等,2006)以来,关于已获得的FVIII抑制剂的大量新数据已经发布,因此需要更新指南。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号